The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a reviewClaire J.H. Kramer, Wilma E. Mesker, Kiki M. H. Vangangelt et al.|Breast Cancer Research and Treatment|2018Cited by 106
The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancerKiki M. H. Vangangelt, Wilma E. Mesker, Daniëlle Cohen et al.|International Journal of Cancer|2020Cited by 72
Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinomaKiki M. H. Vangangelt, Wilma E. Mesker, Gabi W. van Pelt et al.|Breast Cancer Research and Treatment|2017Cited by 67
Standardization of the tumor-stroma ratio scoring method for breast cancer researchSophie C. Hagenaars, Wilma E. Mesker, Janina Kulka et al.|Breast Cancer Research and Treatment|2022Cited by 51